Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Resident, Internal Medicine, University of North Carolina at Chapel Hill School of Medicine 1994 - 1996
  • Intern, Internal Medicine, University of North Carolina at Chapel Hill School of Medicine 1993 - 1994
  • M.D., University of Virginia 1993
• 

  Duke Appointment History

  • Associate Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition, Medicine 2010 - 2017
  • Assistant Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition, Medicine 2006 - 2010
  • Assistant Clinical Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition, Medicine 2002 - 2006
  • Associate in the Department of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition, Medicine 1998 - 2001
• Research
• 

  Fellowships, Supported Research, & Other Grants

  • EMPA-KIDNEY. A Multicentre International Randomized Parallel Group Double-Blind Placebo-Controlled Clinical Trial of Empagliflozin Once Daily To Assess Cardio-Renal Outcomes in Patients With Chronic Kidney Disease awarded by Boehringer Ingelheim/University of Oxford 2017
  • Predictive Algorithm and Reinforcement Learning for Diabetes Management: (PEARL-DM) awarded by DCRI Innovation Grant/Duke Forge 2017
  • Consolidated Sotagliflozin Study Program (SOTA) Non-CV Outcomes awarded by Sanofi 2017
  • Advanced Clinical Trials to Test Artificial Pancreas (AP) Device Systems in Type 1 Diabetes (UC4). NIDDK Cooperative Agreement awarded by NIDDK 2016
  • Albiglutide Phase IV HARMONY Outcomes Trial Protocol GLP116174 awarded by GSK 2015
  • Vitamin D and Type 2 Diabetes Study (D2d) awarded by NIDDK 2013
  • TECOS: A Phase III, Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus awarded by Merck 2008
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • McHugh, K, DeVore, AD, Wu, J, Matsouaka, RA, Fonarow, GC, Heidenreich, PA, Yancy, CW, Green, JB, Altman, N, and Hernandez, AF. "Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review." Journal of the American College of Cardiology 73, no. 5 (February 2019): 602-611. (Review)  Full Text
    • Herrington, WG, Preiss, D, Haynes, R, von Eynatten, M, Staplin, N, Hauske, SJ, George, JT, Green, JB, Landray, MJ, Baigent, C, and Wanner, C. "The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study." Clinical Kidney Journal 11, no. 6 (December 2018): 749-761. (Review)  Full Text
    • Montvida, O, Green, JB, Atherton, J, and Paul, SK. "Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes." Diabetic Medicine : a Journal of the British Diabetic Association (October 10, 2018).  Full Text
    • Hernandez, AF, Green, JB, Janmohamed, S, D'Agostino, RB, Granger, CB, Jones, NP, Leiter, LA, Rosenberg, AE, Sigmon, KN, Somerville, MC, Thorpe, KM, McMurray, JJV, Del Prato, S, and Harmony Outcomes committees and investigators, . "Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial." Lancet (London, England) 392, no. 10157 (October 2, 2018): 1519-1529.  Full Text
    • Alfredsson, J, Green, JB, Stevens, SR, Reed, SD, Armstrong, PW, Angelyn Bethel, M, Engel, SS, McGuire, DK, Van de Werf, F, Hramiak, I, White, HD, Peterson, ED, Holman, RR, and TECOS Study Group, . "Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS." Diabetes, Obesity & Metabolism 20, no. 10 (October 2018): 2379-2388.  Full Text
    • DeVore, AD, and Green, JB. "Preventing Heart Failure in Diabetes: Glycemic Targets or Class Effect?." Jacc. Heart Failure 6, no. 10 (October 2018): 831-832.  Full Text
    • McHugh, KR, DeVore, AD, Mentz, RJ, Edmonston, D, Green, JB, and Hernandez, AF. "The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes." Clinical Cardiology 41, no. 9 (September 21, 2018): 1259-1267. (Review)  Full Text
    • Green, JB, Hernandez, AF, D'Agostino, RB, Granger, CB, Janmohamed, S, Jones, NP, Leiter, LA, Noronha, D, Russell, R, Sigmon, K, Del Prato, S, and McMurray, JJV. "Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics." American Heart Journal 203 (September 2018): 30-38.  Full Text
    • Reed, SD, Li, Y, Leal, J, Radican, L, Adler, AI, Alfredsson, J, Buse, JB, Green, JB, Kaufman, KD, Riefflin, A, Van de Werf, F, Peterson, ED, Gray, AM, Holman, RR, and TECOS Study Group, . "Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes, Obesity & Metabolism 20, no. 7 (July 2018): 1732-1739.  Full Text
    • Wittbrodt, ET, Eudicone, JM, Bell, KF, Enhoffer, DM, Latham, K, and Green, JB. "Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population." The American Journal of Managed Care 24, no. 8 Suppl (April 2018): S138-S145.
    • Wittbrodt, ET, Eudicone, JM, Bell, KF, Enhoffer, DM, Latham, K, and Green, JB. "Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population." The American Journal of Managed Care 24, no. 8 Suppl (April 2018): S146-S155.
    • Standl, E, Stevens, SR, Armstrong, PW, Buse, JB, Chan, JCN, Green, JB, Lachin, JM, Scheen, A, Travert, F, Van de Werf, F, Peterson, ED, Holman, RR, and TECOS Study Group, . "Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype." Diabetes Care 41, no. 3 (March 2018): 596-603.  Full Text
    • Cefalu, WT, Kaul, S, Gerstein, HC, Holman, RR, Zinman, B, Skyler, JS, Green, JB, Buse, JB, Inzucchi, SE, Leiter, LA, Raz, I, Rosenstock, J, and Riddle, MC. "Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum." Diabetes Care 41, no. 1 (January 2018): 14-31.  Full Text
    • Sharma, A, Green, JB, Dunning, A, Lokhnygina, Y, Al-Khatib, SM, Lopes, RD, Buse, JB, Lachin, JM, Van de Werf, F, Armstrong, PW, Kaufman, KD, Standl, E, Chan, JCN, Distiller, LA, Scott, R, Peterson, ED, Holman, RR, and TECOS Study Group, . "Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial." Diabetes Care 40, no. 12 (December 2017): 1763-1770.  Full Text
    • Butler, J, Hamo, CE, Filippatos, G, Pocock, SJ, Bernstein, RA, Brueckmann, M, Cheung, AK, George, JT, Green, JB, Januzzi, JL, Kaul, S, Lam, CSP, Lip, GYH, Marx, N, McCullough, PA, Mehta, CR, Ponikowski, P, Rosenstock, J, Sattar, N, Salsali, A, Scirica, BM, Shah, SJ, Tsutsui, H, Verma, S, Wanner, C, Woerle, H-J, Zannad, F, Anker, SD, and EMPEROR Trials Program, . "The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors." European Journal of Heart Failure 19, no. 11 (November 2017): 1390-1400. (Review)  Full Text
    • Navar, AM, Gallup, DS, Lokhnygina, Y, Green, JB, McGuire, DK, Armstrong, PW, Buse, JB, Engel, SS, Lachin, JM, Standl, E, Van de Werf, F, Holman, RR, Peterson, ED, and TECOS Study Group, . "Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin." Hypertension (Dallas, Tex. : 1979) 70, no. 5 (November 2017): 907-914.  Full Text
    • Herbst, R, Bolton, W, Shariff, A, and Green, JB. "Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions." Current diabetes reports 17, no. 9 (September 2017): 67-. (Review)  Full Text
    • Pagidipati, NJ, Navar, AM, Pieper, KS, Green, JB, Bethel, MA, Armstrong, PW, Josse, RG, McGuire, DK, Lokhnygina, Y, Cornel, JH, Halvorsen, S, Strandberg, TE, Delibasi, T, Holman, RR, Peterson, ED, and TECOS Study Group, . "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)." Circulation 136, no. 13 (September 2017): 1193-1203.  Full Text
    • Bethel, MA, Engel, SS, Green, JB, Huang, Z, Josse, RG, Kaufman, KD, Standl, E, Suryawanshi, S, Van de Werf, F, McGuire, DK, Peterson, ED, Holman, RR, and Grp, TECOSS. "Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes Care 40, no. 4 (April 2017): 494-501.  Full Text  Link to Item
    • Bethel, MA, Engel, SS, Green, JB, Huang, Z, Josse, RG, Kaufman, KD, Standl, E, Suryawanshi, S, Van de Werf, F, McGuire, DK, Peterson, ED, Holman, RR, and TECOS Study Group, . "Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes Care 40, no. 4 (April 2017): 494-501.  Full Text
    • Spratt, SE, Pereira, K, Granger, BB, Batch, BC, Phelan, M, Pencina, M, Miranda, ML, Boulware, E, Lucas, JE, Nelson, CL, Neely, B, Goldstein, BA, Barth, P, Richesson, RL, Riley, IL, Corsino, L, McPeek Hinz, ER, Rusincovitch, S, Green, J, Barton, AB, DDC Phenotype Group, , Kelley, C, Hyland, K, Tang, M, Elliott, A, Ruel, E, Clark, A, Mabrey, M, Morrissey, KL, Rao, J, Hong, B, Pierre-Louis, M, Kelly, K, and Jelesoff, N. "Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus." Journal of the American Medical Informatics Association : Jamia 24, no. e1 (April 2017): e121-e128.  Full Text
    • Buse, JB, Bethel, MA, Green, JB, Stevens, SR, Lokhnygina, Y, Aschner, P, Grado, CR, Tankova, T, Wainstein, J, Josse, R, Lachin, JM, Engel, SS, Patel, K, Peterson, ED, Holman, RR, and TECOS Study Group, . "Pancreatic Safety of Sitagliptin in the TECOS Study." Diabetes Care 40, no. 2 (February 2017): 164-170.  Full Text
    • Cooper, LB, Mi, X, Mentz, RJ, Green, JB, Anstrom, KJ, Hernandez, AF, and Curtis, LH. "Management of newly treated diabetes in Medicare beneficiaries with and without heart failure." Clinical Cardiology 40, no. 1 (January 2017): 38-45.  Full Text
    • Ikeno, F, Brooks, MM, Nakagawa, K, Kim, M-K, Kaneda, H, Mitsutake, Y, Vlachos, HA, Schwartz, L, Frye, RL, Kelsey, SF, Waseda, K, Hlatky, MA, and BARI-2D Study Group, . "SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial." Journal of the American College of Cardiology 69, no. 4 (January 2017): 395-403.  Full Text
    • Josse, RG, Majumdar, SR, Zheng, Y, Adler, A, Bethel, MA, Buse, JB, Green, JB, Kaufman, KD, Rodbard, HW, Tankova, T, Westerhout, CM, Peterson, ED, Holman, RR, Armstrong, PW, and TECOS Study Group, . "Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial." Diabetes, Obesity & Metabolism 19, no. 1 (January 2017): 78-86.  Full Text
    • Coch, RW, and Green, JB. "Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight." Nutrition, metabolism, and cardiovascular diseases : NMCD 26, no. 9 (September 2016): 767-772. (Review)  Full Text
    • McGuire, DK, Van de Werf, F, Armstrong, PW, Standl, E, Koglin, J, Green, JB, Bethel, MA, Cornel, JH, Lopes, RD, Halvorsen, S, Ambrosio, G, Buse, JB, Josse, RG, Lachin, JM, Pencina, MJ, Garg, J, Lokhnygina, Y, Holman, RR, Peterson, ED, and Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group, . "Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial." Jama Cardiology 1, no. 2 (May 2016): 126-135.  Full Text
    • Barnard, K, Lakey, WC, Batch, BC, Chiswell, K, Tasneem, A, and Green, JB. "Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?." Plos One 11, no. 5 (January 2016): e0156068-null.  Full Text  Open Access Copy
    • Espeland, MA, Probstfield, J, Hire, D, Redmon, JB, Evans, GW, Coday, M, Lewis, CE, Johnson, KC, Wilmoth, S, Bahnson, J, Dulin, MF, Green, JB, Knowler, WC, Kitabchi, A, Murillo, AL, Osei, K, Rehman, SU, Cushman, WC, Look AHEAD Research Group, , and ACCORD Study Group, . "Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions." American Journal of Hypertension 28, no. 8 (August 2015): 995-1009.  Full Text
    • Green, JB, Bethel, MA, Armstrong, PW, Buse, JB, Engel, SS, Garg, J, Josse, R, Kaufman, KD, Koglin, J, Korn, S, Lachin, JM, McGuire, DK, Pencina, MJ, Standl, E, Stein, PP, Suryawanshi, S, Van de Werf, F, Peterson, ED, Holman, RR, and TECOS Study Group, . "Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes." The New England Journal of Medicine 373, no. 3 (July 2015): 232-242.  Full Text
    • Green, JB. "Update in endocrinology: evidence published in 2014." Annals of internal medicine 162, no. 9 (May 2015): W91-W95.  Full Text
    • Bethel, MA, Green, JB, Milton, J, Tajar, A, Engel, SS, Califf, RM, Holman, RR, Armstrong, PW, Buse, JB, Josse, RG, Kaufman, K, Koglin, J, Korn, S, Lachin, JM, McGuire, DK, Standl, E, Stein, P, Suryawanshi, S, and Van de Werf, F. "Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes, Obesity and Metabolism 17, no. 4 (April 1, 2015): 395-402.  Full Text
    • Bethel, MA, Green, JB, Milton, J, Tajar, A, Engel, SS, Califf, RM, Holman, RR, and TECOS Executive Committee, . "Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes, Obesity & Metabolism 17, no. 4 (April 2015): 395-402.  Full Text
    • Koshizaka, M, Lopes, RD, Reyes, EM, Gibson, CM, Schulte, PJ, Hafley, GE, Hernandez, AF, Green, JB, Kouchoukos, NT, Califf, RM, Ferguson, TB, Peterson, ED, and Alexander, JH. "Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial." American Heart Journal 169, no. 1 (January 2015): 175-184.  Full Text
    • Magee, MF, Tamis-Holland, JE, Lu, J, Bittner, VA, Brooks, MM, Lopes, N, Jacobs, AK, Detre, KM, Kelsey, SF, Orchard, TJ, Thomas, SB, Tyrrell, KS, Rana, JS, Averbach, F, MacGregor, JM, O'Neal, SM, Pitluga, K, Sansing, V, Tranchine, M, Crow, SW, Bertolet, M, Hardison, R, Kip, K, Lombardero, M, Janiszewski, S, Protivnak, D, Reiser, S, Barton, S, Guo, P, Kushner, Y, Martin, JP, Kania, C, Kania, M, O'Donnell, J, Maxwell, RA, Frye, RL, Goldberg, S, Rosenberg, Y, Desvigne-Nickens, P, Ershow, A, Gordon, D, Paltoo, D, Jones, TLZ, Hueb, W, Ramires, J, Wajchenberg, BL, Martinez, EE, Oliveira, SA, Ribeiro, EE, Perin, M, Betti, R, Schwartz, L, Steiner, G, Barolet, A, Groenewoud, Y, Mighton, L, Camelon, K, O'Rourke, R, Blodgett, J, Sako, E, Nicastro, J, Prescott, R, Rihal, C, Kennedy, F, Barsness, G, Basu, A, Clavell, A, Frye, R, Holmes, DR, Lerman, A, Mullaney, C, Reeder, G, Rizza, R, Schaff, H, Smith, S, and Somers, V. "Sex, prescribing practices and guideline recommended, blood pressure, and LDL cholesterol targets at baseline in the BARI 2D trial." International Journal of Endocrinology 2015 (January 1, 2015).  Full Text
    • Green, JB. "Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox." Postgraduate medicine 126, no. 3 (May 2014): 190-204. (Review)  Full Text
    • "Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV Trial." American Heart Journal 169, no. 1 (January 1, 2014): 175-184.  Full Text
    • Ismail-Beigi, F, Lombardero, MS, Escobedo, J, Genuth, S, Green, J, Massaro, E, Mooradian, AD, Ovalle, F, Whitehouse, F, and Zonszein, J. "Determinants of successful glycemic control among participants in the BARI 2D Trial: A Post-hoc Analysis." Journal of Diabetes and its Complications 28, no. 1 (2014): 101-109.  Full Text
    • Green, JB, Bethel, MA, Paul, SK, Ring, A, Kaufman, KD, Shapiro, DR, Califf, RM, and Holman, RR. "Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease." American Heart Journal 166, no. 6 (December 2013): 983-989.e7.  Full Text
    • Povsic, TJ, Sloane, R, Zhou, J, Pieper, CF, Pearson, MP, Peterson, ED, Green, JB, Cohen, HJ, and Morey, MC. "Lower levels of circulating progenitor cells are associated with low physical function and performance in elderly men with impaired glucose tolerance: a pilot substudy from the VA Enhanced Fitness trial." The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 68, no. 12 (December 2013): 1559-1566.  Full Text
    • "Depletion of circulating progenitor cells precedes overt diabetes: A substudy from the VA enhanced fitness trial." Journal of Diabetes and Its Complications 27, no. 6 (November 1, 2013): 633-636.  Full Text
    • Povsic, TJ, Sloane, R, Green, JB, Zhou, J, Pieper, CF, Pearson, MP, Peterson, ED, Cohen, HJ, and Morey, MC. "Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial." Journal of Diabetes and Its Complications 27, no. 6 (November 2013): 633-636.  Full Text
    • Pop-Busui, R, Lu, J, Brooks, MM, Albert, S, Althouse, AD, Escobedo, J, Green, J, Palumbo, P, Perkins, BA, Whitehouse, F, Jones, TLZ, and BARI 2D Study Group, . "Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort." Diabetes care 36, no. 10 (October 2013): 3208-3215.  Full Text
    • Lakey, WC, Barnard, K, Batch, BC, Chiswell, K, Tasneem, A, and Green, JB. "Are current clinical trials in diabetes addressing important issues in diabetes care?." Diabetologia 56, no. 6 (June 2013): 1226-1235. (Review)  Full Text
    • "Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease." American Heart Journal 166, no. 6 (January 1, 2013).  Full Text
    • Ismail-Beigi, F, Lombardero, MS, Escobedo, J, Genuth, S, Green, J, Massaro, E, Mooradian, AD, Ovalle, F, Whitehouse, F, and Zonszein, J. "Determinants of successful glycemic control among participants in the BARI 2D Trial: A Post-hoc Analysis." Journal of Diabetes and its Complications (2013).  Full Text
    • Lakey, WC, Barnard, K, Batch, BC, Chiswell, K, Tasneem, A, and Green, JB. "Are current clinical trials in diabetes addressing important issues in diabetes care?." Diabetologia 56, no. 6 (2013): 1226-1235.  Full Text
    • Green, JB, Lakey, W, Barnard, K, Batch, B, Bethel, M, Chiswell, K, and Tasneem, A. "State of diabetes-related trials in the clinicaltrials.gov dataset." Diabetologia 55 (October 1, 2012): S90-S91.  Link to Item
    • Morey, MC, Pieper, CF, Edelman, DE, Yancy Jr, WS, Green, JB, Lum, H, Peterson, MJ, Sloane, R, Cowper, PA, Bosworth, HB, Huffman, KM, Cavanaugh, JT, Hall, KS, Pearson, MP, and Taylor, GA. "Enhanced fitness: a randomized controlled trial of the effects of home-based physical activity counseling on glycemic control in older adults with prediabetes mellitus." Journal of the American Geriatrics Society 60, no. 9 (September 2012): 1655-1662. (Academic Article)  Full Text
    • Green, JB. "The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety." Postgrad Med 124, no. 4 (July 2012): 54-61. (Review)  Full Text  Link to Item
    • Schwartz, AV, Margolis, KL, Sellmeyer, DE, Vittinghoff, E, Ambrosius, WT, Bonds, DE, Josse, RG, Schnall, AM, Simmons, DL, Hue, TF, Palermo, L, Hamilton, BP, Green, JB, Atkinson, HH, O'Connor, PJ, Force, RW, and Bauer, DC. "Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial." Diabetes Care 35, no. 7 (July 2012): 1525-1531.  Full Text
    • Stiles, MC, Seaquist, ER, Yale, JF, Green, JB, Katz, LA, Kempainen, S, Light, LS, Pepper, PV, Zhang, Z-M, and Soliman, EZ. "Is silent myocardial infarction more common in women with type 2 diabetes than in men?." J Diabetes Complications 26, no. 2 (March 2012): 118-122.  Full Text  Link to Item
    • Koshizaka, M, Green, JB, and Alexander, JH. "Glycemic management in diabetes and the associated cardiovascular risk: are we helping or hurting our patients?." Circ J 76, no. 7 (2012): 1572-1580. (Review)  Link to Item
    • Hall, KS, Pieper, CF, Edelman, DE, Yancy Jr, WS, Green, JB, Lum, H, Peterson, MJ, Sloane, R, Cowper, PA, Bosworth, HB, Huffman, KM, Cavanaugh, JT, Chapman, JG, Pearson, MP, Howard, TA, Ekelund, CC, McCraw, BL, Burrell, JB, Taylor, GA, and Morey, MC. "Lessons learned when innovations go awry: a baseline description of a behavioral trial-the Enhancing Fitness in Older Overweight Veterans with Impaired Fasting Glucose study." Translational Behavioral Medicine 1, no. 4 (November 2011): 573-587. (Academic Article)  Full Text
    • Buse, JB, Dailey, G, Ahmann, AA, Bergenstal, RM, Green, JB, Peoples, T, Tanenberg, RJ, and Yang, Q. "Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience." Diabetes Technol Ther 13, no. 6 (June 2011): 601-606.  Full Text  Link to Item
    • Chen, LC, and Green, JB. "First reported case of unilateral Graves' disease in the left lobe of a bilobar thyroid gland." Thyroid 21, no. 6 (June 2011): 683-686.  Full Text  Link to Item
    • Jiang, W, Ladd, S, Martsberger, C, Feinglos, M, Spratt, SE, Kuchibhatla, M, Green, J, and Krishnan, R. "Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy." J Clin Psychopharmacol 31, no. 2 (April 2011): 207-213.  Full Text  Link to Item
    • Barnard, K, Cox, ME, and Green, JB. "Clinical utility of fixed combinations of sitagliptin-metformin in treatment of type 2 diabetes." Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy 3 (October 27, 2010): 363-372.  Full Text
    • Cox, ME, Rowell, J, Corsino, L, and Green, JB. "Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy." Drug Healthc Patient Saf 2 (2010): 7-19.  Link to Item
    • Corsino, L, Cox, ME, Rowel, J, and Green, JB. "Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes." Clin Med Ther 1 (August 27, 2009): 1103-1119.  Link to Item
    • Pop-Busui, R, Lombardero, M, Lavis, V, Forker, A, Green, J, Korytkowski, M, Sobel, BE, Jones, TLZ, and BARI 2D Study Group, . "Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study)." Am J Cardiol 104, no. 1 (July 1, 2009): 52-58.  Full Text  Link to Item
    • Gerstein, HC, Miller, ME, Byington, RP, Goff, DC, Bigger, JT, Buse, JB, Cushman, WC, Genuth, S, Ismail-Beigi, F, Grimm, RH, Probstfield, JL, Simons-Morton, DG, Friedewald, WT, Gotto, AM, Bailey, K, Gohdes, D, Haffner, S, Hiss, R, Jamerson, K, Lee, K, Nathan, D, Sowers, J, Walters, L, Ginsberg, HN, Yusuf, S, Punthakee, Z, Russo, R, Anand, S, Cracknell, B, Cukierman-Yaffe, T, Gafni, A, Guyatt, G, Hall, S, Kaszyca, J, Lonn, E, McLeod, D, Read, K, Reiding, V, Shehadeh, N, Tadeson, B, Thompson, K, Vallis, M, Vasudeva, V, Wilderman, I, Smith, A, Stanton, I, Capes, S, Danby, S, Harper, W, Harvey, P, Hunt, D, Manjoo, P, Moroso, A, Otto, R, Prebtani, A, Valla, T, Davis, A, Hill, KL, McCarthy, V, Edwards, AL, Mitchell, DJ, Clearwaters, MA, Dielissen, C, Gillam, M, Hammond, B, Jensen, H, Kherani, A, Lau, D, Pringle, V, Rabi, D, Sigal, R, Smith, C, Walker, M, Williams, G, Joyce, C, Parsons, M, Rowe, B, Burton, J, Chandurkar, V, Coady-McDonald, S, Gibbons, D, Kovacs, C, Murphy, B, and Smart, R. "Effects of intensive glucose lowering in type 2 diabetes." New England Journal of Medicine 358, no. 24 (June 12, 2008): 2545-2559.  Full Text
    • Green, J, and Feinglos, M. "New combination treatments in the management of diabetes: focus on sitagliptin-metformin." Vasc Health Risk Manag 4, no. 4 (2008): 743-751. (Review)  Link to Item
    • Green, JB, and Feinglos, MN. "Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity." Current Diabetes Reports 7, no. 5 (October 2007): 369-375. (Review)  Full Text
    • Green, J, and Feinglos, M. "Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm." Int J Clin Pract Suppl , no. 154 (August 2007): 3-11. (Review)  Full Text  Link to Item
    • Friedewald, WT, Buse, JB, Bigger, JT, Byington, RP, Cushman, WC, Genuth, S, Gerstein, HC, Ginsberg, HN, Goff, DC, Grimm, RH, Probstfield, JL, Simons-Morton, DG, Russo, R, Thompson, K, Cukierman-Yaffe, T, Gafni, A, Shamis, I, Shehadeh, N, Tadeson, B, Vasudeva, V, Yusuf, S, Punthakee, Z, Capes, S, Manjoo, P, Smith, A, Stanton, I, Valla, T, Danby, S, Harper, W, Harvey, P, Hunt, D, Moroso, A, Otto, R, Prebtani, A, Davis, A, Hill, KL, McCarthy, V, Edwards, AL, Clearwaters, MA, Mitchell, DJ, Hammond, B, Jensen, H, Kherani, A, Lau, D, Rabi, D, Smith, C, Walker, M, Williams, G, Joyce, C, Parsons, M, Rowe, B, Gibbons, D, Burton, J, Chandurkar, V, Coady-McDonald, S, Kovacs, C, Murphy, B, Smart, R, Varghese, S, Mereu, L, Ryan, E, Senior, P, Germsheid, J, Kirkland, P, Werbiski-Wood, P, Mawani, S, Abe, J, Dalton, K, Jeffrys, A, Mac-Donald, C, Makhani, N, Paty, B, Pick, M, Schwanke, B, Tennant, M, Varma, S, Zimmerman, W, and Belanger, A. "Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods." American Journal of Cardiology 99, no. 12 (June 18, 2007).  Full Text
    • Green, J, and Feinglos, M. "Update on type 2 diabetes mellitus: Understanding changes in the diabetes treatment paradigm." International Journal of Clinical Practice 61, no. SUPPL. 154 (2007): 3-11.  Full Text
    • Green, JB, and Feinglos, MN. "Are sulfonylureas passé?." Curr Diab Rep 6, no. 5 (November 2006): 373-377. (Review)  Link to Item
    • Weber, TJ, Green, JB, Chow, H, Spitz, A, and Wagner, GS. "How bone density testing influenced osteoporosis treatment in a community hospital." N C Med J 61, no. 6 (November 2000): 321-324.  Link to Item

  • Book Sections

    • Green, JB. "Disorders of monosaccharide metabolism." In Garner and Klintworth's Pathobiology of Ocular Disease Part B, Third Edition, 1005-1018. January 1, 2007.

  • Conference Papers

    • McHugh, K, Wu, J, Matsouaka, RA, DeVore, AD, Fonarow, GC, Heidenreich, PA, Yancy, CW, Green, JB, Altman, N, and Hernandez, AF. "Diabetes is Associated with Worse In-Hospital and 30-Day Post-Discharge Morbidity in Patients with Heart Failure with Preserved Ejection Fraction: Findings from the Get With The Guidelines Heart Failure Registry." : Elsevier BV, August 2018.  Full Text
    • Engel, SS, Bethel, MA, Garg, J, Stevens, SR, Lokhnygina, Y, Josse, RG, Green, JB, Peterson, ED, Holman, RR, and Grp, TECOSS. "Time to insulin in the Trial Evaluating Cardiovascular Outomes with Sitagliptin (TECOS)." September 2017.  Link to Item
    • Gray, AM, Leal, J, Reed, SD, Li, Y, Graham, F, Green, JB, Kaufman, KD, Radican, L, Alfredsson, J, Buse, J, Riefflin, A, Van de Werf, F, Peterson, ED, and Holman, RR. "Resource use and UK-perspective costs in patients with type 2 diabetes during the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." September 2017.  Link to Item
    • Paul, S, Green, JB, Atherton, J, and Montvida, O. "Risk of pancreatic diseases by second-line anti diabetes drug class: real world based evidence." September 2017.  Link to Item
    • Green, JB, Alfredsson, J, Stevens, SR, Reed, SD, McGuire, DK, Armstrong, PW, Engel, SS, Bethel, MA, de Werf, FV, Peterson, ED, and Holman, RR. "Sex differences in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." August 2016.  Link to Item
    • Josse, RG, Majumdar, SR, Zheng, Y, Buse, JB, Green, JB, Kaufman, KD, Peterson, ED, Holman, RR, Armstrong, PW, and Grp, TECOSS. "Sitagliptin and risk of fractures in type 2 diabetes: results from the TECOS trial." August 2016.  Link to Item
    • Lee, SW, Welsh, JB, Green, JB, Joyce, C, Tamborlane, WV, and Kaufman, FR. "Successful transitions from MDI therapy to sensor-augmented pump therapy in the STAR 3 study: system settings and behaviours." September 2011.  Link to Item
    • Calles-Escandon, J, Light, L, Lovato, L, Getaneh, A, Simmons, D, Kirk, J, Bonds, D, Banerji, MA, Green, JB, Menon, L, Moogali, A, and Bergenstal, RM. "Glycaemia management of minority participants in ACCORD." September 2010.  Link to Item
    • Green, JB, Ahmann, A, Bergenstal, RM, Dailey, G, Tanenberg, R, Buse, JB, and Grp, STAR3S. "Glucose control in adults during a 1-year randomised controlled trial comparing sensor-augmented pump therapy and multiple daily injection therapy: STAR 3 study." September 2010.  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.